We are committed to sharing details of our relationships with patient organisations, healthcare professionals and appropriate administrative staff; as well as details of all donations and grants provided to institutions, organisations or associations that are comprised of healthcare professionals and/or that provide healthcare or conduct research.

Disclosure of patient organisation support

Support for healthcare professionals and healthcare organisations during 2015 and each subsequent calendar year is published on the Association of the British Pharmaceutical Industry (ABPI) central platform on 30 June of the following year.

2019 disclosures

Organisation Registration number Website Details Amount
Multiple Sclerosis Trust 1088353 Click here Sponsorship of MS Trust Conference - November 2019 £3,650
The Migraine Trust 1081300  Click here Corporate membership £45,000
The Neurological Alliance 1039034 Click here Corporate membership £15,548


Patient organisations and patient advocacy

We believe in the value of relationships to develop a deeper understanding of patient needs. 

Because we believe in the value of our relationships with patient organisations, we work hard to develop a deeper understanding of patient needs and to integrate such insights throughout our organisation. In this way, we create transparent partnerships that are central to our work of supporting patients and their caregivers on the journey to improved health and happy lives. 

Teva Guiding Principles for Patient Organisation Engagement:

Ethical Conduct & Integrity

Teva personnel are expected to maintain the highest standards of integrity in their relations with patient organisations.


Teva will be open and transparent regarding relationships with patient organisations.

Teva will publicly disclose financial support and significant non-financial support provided to patient organisations. Further, patient organisations may publish Teva’s support of their programs as they deem appropriate. Teva’s global policy on patient organisation engagement is available to patient groups.

Mutual Benefit

Teva’s support of patient organisations is focused on improving the welfare of patients, families and caregivers. Any activity undertaken with patient organisations must clearly demonstrate benefit to the patients whose interests the patient groups represent.

Successful partnerships between patient organisations and Teva must provide mutual benefit to both organisations.  Therefore, Teva will seek to build mutually beneficial relationships with patient organisations in areas where there is alignment around objectives and priorities.


A patient organisation in partnership with Teva must not have its independence compromised, nor should it be perceived to be compromised, and patient organisations retain the right to publicly object to the positions of the company.


Every interaction between company personnel (and its representatives) and patient organisations will comply with all government rules, regulations and guidelines, as well as with all applicable Teva policies.


Teva must not use interactions and relationships with patient organisations to promote its products or increase commercial awareness of its products, except in countries that allow Direct to Consumer Advertising, and only when done in compliance with all applicable laws and Teva policies governing product promotion.

Contributions to patient organisations  

Teva’s contributions to patient organisations last year, to support these organisations in delivering their respective goals and objectives, are published on our corporate website here.

This report will be updated annually.